Rom E. Eliaz
Impact in
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
Papers in
-
- RNA Interference and Gene Delivery 4
- Glycosylation and Glycoproteins Research 2
- Viral Infectious Diseases and Gene Expression in Insects 1
-
- biodegradable polymer synthesis and properties 2
- Co-authors
- Francis C. Szoka (4 shared papers)Joseph Kost (5 shared papers)Shlomo Nir (2 shared papers)Cornelia Marty (1 shared paper)David Wallach (1 shared paper)Eli Eyal (3 shared papers)Victor Abler (2 shared papers)Yossi Gilgun‐Sherki (1 shared paper)
- Journals
- Journal of Biomedical Materials Research (2 papers)Drug and Alcohol Dependence (1 paper)Cytokine (1 paper)Israel Journal of Chemistry (1 paper)Gene Therapy (1 paper)
- Partner nations
- IsraelUnited StatesSwitzerland
In The Last Decade
Rom E. Eliaz
12 papers receiving 809 citations
Peers
Comparison fields: 5 of 93
- Pharmaceutical Science 182
- Biomaterials 352
- Molecular Medicine 85
- Cell Biology 109
- Molecular Biology 360
Countries citing papers authored by Rom E. Eliaz
This map shows the geographic impact of Rom E. Eliaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rom E. Eliaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rom E. Eliaz more than expected).
Fields of papers citing papers by Rom E. Eliaz
This network shows the impact of papers produced by Rom E. Eliaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rom E. Eliaz. The network helps show where Rom E. Eliaz may publish in the future.
Co-authors
The 25 scholars most cited alongside Rom E. Eliaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Liposome-encapsulated doxorubicin targeted to CD44: a strategy to kill CD44-overexpressing tumor cells. | 2001 | 314 |
| 2 | 2000 | 148 | |
| 3 | 2004 | 137 | |
| 4 | 2016 | 50 | |
| 5 | 2002 | 48 | |
| 6 | 2000 | 47 | |
| 7 | 2016 | 35 | |
| 8 | 2004 | 30 | |
| 9 | 1996 | 20 | |
| 10 | 2016 | 16 | |
| 11 | 2000 | 7 | |
| 12 | 2005 | 1 |
About Rom E. Eliaz
Rom E. Eliaz is a scholar working on Molecular Biology, Biomaterials, Genetics, Neurology and Radiology, Nuclear Medicine and Imaging, having authored 12 papers that have together received 853 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (4 papers), Glycosylation and Glycoproteins Research (2 papers), biodegradable polymer synthesis and properties (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), Bone Tissue Engineering Materials (2 papers), Virus-based gene therapy research (2 papers) and Viral Infectious Diseases and Gene Expression in Insects (1 paper). The work is most often cited by research in Pharmaceutical Science (182 citations), Biomaterials (352 citations), Molecular Medicine (85 citations), Cell Biology (109 citations) and Molecular Biology (360 citations). Rom E. Eliaz has collaborated with scholars based in Israel, United States and Switzerland. Frequent co-authors include Francis C. Szoka, Joseph Kost, Shlomo Nir, Cornelia Marty, David Wallach, Eli Eyal, David Wallach, Victor Abler, Yossi Gilgun‐Sherki and Hussein Hallak. Their work appears in journals such as Journal of Biomedical Materials Research, Drug and Alcohol Dependence, Cytokine, Israel Journal of Chemistry and Gene Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.